Quick Takeaways
- Sealbond Ltd filed SCHEDULE 13D/A for Dogwood Therapeutics, Inc. Common Stock, $0.0001 par value (DWTX).
- Disclosed ownership: 16%.
- Date of event: 12 Mar 2025.
Sealbond Ltd - 12 Mar 2025 SCHEDULE 13D/A Report for Dogwood Therapeutics, Inc. Common Stock, $0.0001 par value (DWTX)
- Filing Manager
- Sealbond Ltd
- Reporting Manager
- Sealbond Limited
- Symbol
- DWTX
- Shares outstanding
- 1,329,453 shares
- Disclosed Ownership
- 211,383 shares
- Ownership
- 16%
- Form type
- SCHEDULE 13D/A
- Filing time
- 17 Mar 2025, 21:11:55 UTC
- Date of event
- 12 Mar 2025
- Next filing
- 25 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Sealbond Ltd disclosed 16% ownership in Dogwood Therapeutics, Inc. Common Stock, $0.0001 par value (DWTX) on 12 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Mar 2025, 21:11.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Sealbond Limited | 16% | 211,383 | 211,383 | 0 | /s/ Wong Wun Lam | Wong Wun Lam, Director | 0002040446 |
| CK Life Sciences Int'l., (Holdings) Inc. | 16% | 211,383 | 211,383 | 0 | /s/ Yu Ying Choi Alan Abel | Yu Ying Choi Alan Abel, Director | |
| Conjoint Inc. | 0% | 0 | 0 | 0 | /s/ Wong Wun Lam | Wong Wun Lam, Director |